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Since its discovery in 1994, IL-15 has been studied in the
context of its structural cousin, IL-2 (1). Early biochemical
and in vitro lymphocyte studies revealed many similarities
between IL-15 and IL-2: (a) IL-2 and IL-15 constitute the
only two members of a family of cytokines containing a
 
four 
 
a
 
 helix bundle; (b) the heterotrimeric receptors for
IL-2 and IL-15 share both the IL-2/15R
 
b 
 
and IL-2R
common 
 
g
 
 (IL-2R
 
g
 
 or 
 
g
 
c) chains; (c) the shared IL-2/
15R
 
b
 
 and 
 
g
 
c chains are responsible for downstream cyto-
plasmic signals; and (d) the IL-2R
 
a
 
 and IL-15R
 
a
 
 chains,
which confer specificity to IL-2R and IL-15R for their re-
spective ligands, are closely related proteins (2). However,
the highly restricted expression of IL-2 and IL-2R
 
a
 
 to acti-
vated T cells suggests that IL-2R signals perform unique
functions in adaptive T cells, whereas the pleiotropic ex-
pression of IL-15 and IL-15R
 
a
 
 hints at a much broader
role for IL-15R in multiple cell types. Indeed, distinct
functions for IL-2 and IL-15 have been suggested from in
vivo studies. IFN regulatory factor (IRF-1)–deficient mice
lack NK cells due to an inability of their bone marrow
stroma to elaborate IL-15, demonstrating a unique role for
IL-15 in supporting NK cell development (3). Compara-
tive studies of IL-2R
 
a
 
–deficient and IL-2/15R
 
b
 
–deficient
mice (where only the latter should lack IL-15R signals)
suggest that IL-15 might also be important for the differen-
tiation of NK T cells and certain subsets of intraepithelial
lymphocytes (IELs) (4, 5). Finally, exogenous IL-15, but
not IL-2, selectively induces the proliferation of memory
 
phenotype CD8
 
1
 
 T cells in normal mice (6). Thus, emerg-
ing from the shadow of IL-2, IL-15 may serve a wide range
of immune functions.
The unique roles for IL-15 in vivo have become clearer
 
with the initial reports of IL-15–deficient (IL-15
 
2
 
/
 
2
 
) mice
by Kennedy et al. in this issue (7) and IL-15R
 
a
 
2
 
/
 
2 
 
mice
(8). While IL-2
 
2
 
/
 
2
 
 and IL-2R
 
a
 
2
 
/
 
2
 
 mice spontaneously ac-
cumulate activated T and B cells and die prematurely from
autoimmune disease, IL-15
 
2
 
/
 
2
 
 and IL-15R
 
a
 
2
 
/
 
2
 
 mice are
generally healthy, lymphopenic, and specifically lack NK
cells, NK T cells, intestinally derived subsets of IELs, and
activated CD8
 
1
 
 T cells (7–10). The loss of these cells dem-
onstrates that IL-15 signals via IL-15R
 
a
 
 are critical for
lymphoid development and/or maintenance, particularly
for innate immune cells. By showing that 7 d of IL-15
treatment salvages these cells, Kennedy et al. suggest that
the peripheral maintenance of these cells may be a promi-
nent aspect of IL-15 function (7). This observation is con-
sistent with prior work indicating that IL-15 supports pe-
ripheral memory phenotype CD8
 
1
 
 T cells (6, 8). It also
suggests that CD8
 
1
 
 T cells may partially resemble innate
immune cells. Furthermore, IL-15 also induces the activa-
tion and cytotoxicity of mature NK cells (11). In addition,
IL-15 clearly regulates innate immune cell differentiation.
Bone marrow stroma elaborates IL-15 to support NK cell
differentiation (3, 12), and IL-15 skews the differentiation
of thymic progenitors towards NK T cells (13; Fig. 1).
Thus, IL-15 is critical for mediating the development, ho-
meostasis, and activation of innate immune cells.
The finding that IL-15
 
2
 
/
 
2
 
 and IL-15R
 
a
 
2
 
/
 
2
 
 mice are
lymphopenic suggests that IL-15 may also support adaptive
CD4
 
1
 
 and CD8
 
1
 
 T cells (7, 8). Whether IL-15 regulates
adaptive lymphocyte differentiation remains to be eluci-
dated, but the reduced thymic cellularity of IL-15R
 
a
 
2
 
/
 
2
 
mice suggests that this may be the case (8). Nevertheless, it
is clear that IL-15 provides tonic proliferative and/or sur-
vival signals to support mature lymphocytes (6–8). As IL-15
is elaborated by nonlymphoid (stromal and epithelial) cells,
physiological delivery of IL-15 to adaptive T lymphocytes
may predominantly occur within nonlymphoid stroma. For
example, both muscle and epithelial cells express and re-
spond to IL-15, so tissue-bound lymphocytes may share
these tissue pools of IL-15 and use them for homeostatic
maintenance (14, 15). In this context, the intestinal mu-
cosa—which harbors large numbers of innate immune cells
responding to luminal microbes, and whose epithelial and
stromal cells elaborate IL-15—is an excellent microenvi-
ronment for such interactions. Future studies of mucosal
and other tissue-bound lymphocytes are thus likely to re-
veal novel insights into how IL-15 supports lymphocyte
homeostasis.
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The propensity of antigen-experienced, or memory, T
lymphocytes to circulate through nonlymphoid tissues sug-
gests that IL-15 function may extend to the maintenance of
immunological memory. Because memory T cells may ex-
press elevated levels of IL-15R
 
a
 
 and IL-2/15R
 
b
 
 as a result
of antigenic exposure, they may proliferate and survive in
response to tissue-derived IL-15. As noted above, such
stimulation could occur within nonlymphoid stroma, in
the relative absence of cognate antigens, active inflamma-
tion, or lymphocyte-derived cytokines. Moreover, IL-15 is
expressed by activated endothelial cells and may regulate
the capacity of T lymphocytes to migrate across endothelial
barriers to target tissues (16). Thus, several approaches may
be required to fully understand the scope of IL-15’s poten-
tial memory function. It will also be important to deter-
mine which cellular sources of IL-15 are responsible for
supporting memory cells. How IL-15 may be involved in
the maintenance of immunological memory is clearly an
important and testable issue that is greatly facilitated by the
availability of IL-15
 
2
 
/
 
2
 
 and IL-15R
 
a
 
2
 
/
 
2
 
 mice.
An essential role for IL-15 in immune responses is high-
lighted by the inability of IL-15
 
2
 
/
 
2
 
 mice to survive vac-
cinia virus infection (7). While NK cell antiviral responses
are likely to be compromised in these mice, the selective
loss of memory phenotype CD8
 
1
 
 T cells also raises the
possibility that CD8
 
1
 
 T cell antiviral responses may also be
defective. Since CD8
 
1
 
 T cells resemble classical innate im-
mune cells in their homeostatic reliance on IL-15, and
since IL-15 activates NK cells, it is possible that IL-15 also
stimulates CD8
 
1
 
 T cell cytolytic competence. Additional
studies are now needed to define which IL-15 function(s) is
essential for successful antiviral responses. Other immune
responses may be less reliant on IL-15, and understanding
the role(s) of IL-15 in different systems should lead to a
better understanding of the mechanisms by which different
immunogens induce distinct innate (and subsequently,
adaptive) immune responses (17; Fig. 1). Moreover, ma-
nipulating the expression or activity of IL-15 and IL-15R
 
a
 
(perhaps in conjunction with other costimulatory mole-
cules) will likely be an important area for modulating im-
mune responses.
The fate of activated T lymphocytes to undergo pro-
grammed cell death or persist as memory cells is central to
the regulation of immune responses. In this context, it is
essential to note that activated cells express both IL-2R
 
a
 
and IL-15R
 
a
 
. IL-2 predisposes activated T cells to undergo
programmed cell death, whereas IL-15 appears to support
proliferation (and possibly survival), so these cells must dis-
tinguish between IL-2R and IL-15R signals. The impor-
tance of this distinction is emphasized by the divergent
phenotypes of the mutant mice. This difference forces us to
return to the IL-2R and IL-15R signaling complexes and
ask how the distinction is made. Ligand availability is likely
to be a major factor; activated T cells are the only cells ex-
pressing IL-2, whereas multiple cell types express IL-15.
Differential induction of IL-2R
 
a
 
 and IL-15R
 
a
 
 is another
potential factor. Also, IL-15 binds to IL-15R
 
a
 
 alone with
far greater affinity than IL-2 binds to IL-2R
 
a
 
 alone, so cells
expressing both receptors may preferentially bind to IL-15
under conditions where both cytokines are present (18).
Finally, the possibility remains that IL-15R
 
a
 
 engagement
induces IL-2/15R
 
b
 
 and 
 
g
 
c signaling events that are quanti-
tatively distinct from those initiated by IL-2R
 
a
 
 binding
(19). The strength of these signals may then translate into
Figure 1. IL-15 preferentially
supports innate immune cell de-
velopment and homeostasis.
Upon bacterial or viral infection,
conserved motifs (such as dou-
ble-stranded [ds] RNA or LPS)
result in the release of type I
IFNs (IFN-a/b) from infected
host cells. Type I IFNs activate
macrophages (Mf), stimulating
them to produce IL-15 as well as
inducing the upregulation of co-
stimulatory molecules. IL-15 se-
lectively activates NK cells, NK
T cells, intestinal g/d T cells (g/d
IEL), and CD81 T cells. From a
developmental standpoint, innate
immune cells also appear to rely
more on IL-15R signals. 
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biologically distinct outcomes for the T cell (e.g., a stronger
activation or proliferation stimulus may predispose to pro-
grammed cell death).
In summary, the report by Kennedy et al. strongly rein-
forces the concept that IL-15 performs pleiotropic develop-
mental and homeostatic immune functions, particularly for
innate immune cells (7). Curiously, despite the biochemical
similarities of IL-2R and IL-15R signals, none of the in
vivo biological functions of IL-15 appear to overlap with
IL-2’s critical role in downregulating activated T cells. The
initial findings in IL-15
 
2
 
/
 
2
 
 and IL-15R
 
a
 
2
 
/
 
2
 
 mice prompt
many new questions about how IL-15 mediates these func-
tions. For example, do all IL-15 signals use IL-15R
 
a
 
, and
how are IL-2R and IL-15R signals biochemically distin-
guished? To what extent does IL-15 support lymphocyte
proliferation versus survival? Additional important future di-
rections include understanding IL-15’s diverse roles in: NK
cell differentiation, activation, and proliferation; NK T cell
function; CD8
 
1
 
 T cell activation and homeostasis; mucosal
immunity; innate and adaptive immune responses; and im-
munological memory. It will also be important to deter-
mine whether IL-15 mediates more subtle functions in
CD4
 
1
 
 T cells. As these investigations are completed, it may
become apparent that IL-15 will encompass far broader bio-
logical functions than its scientifically older (but perhaps
evolutionarily younger) cousin, IL-2.
 
This work is supported by National Institutes of Health grants
RO1 DK52751 and AI45860, Digestive Disease Research Center
grant DK42086, and the Gastrointestinal Research Foundation.
 
Submitted: 17 January 2000
Accepted: 18 January 2000
Released online: 28 February 2000
 
References
 
1. Grabstein, K.H., J. Eisenman, K. Shanebeck, C. Rauch, S.
Srinivasan, V. Fung, C. Beers, J. Richardson, M.A. Schoen-
born, M. Ahdieh, et al. 1994. Cloning of a T cell growth fac-
tor that interacts with the beta chain of the interleukin-2 re-
ceptor. 
 
Science.
 
 264:965–968.
2. DiSanto, J.P. 1997. Cytokines: shared receptors, distinct
functions. 
 
Curr. Biol.
 
 7:R424–R426.
3. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T.
Yokochi-Fukuda, T.A. Waldmann, T. Taniguchi, and S.
Taki. 1998. Requirement for IRF-1 in the microenviron-
ment supporting development of natural killer cells. 
 
Nature.
 
391:700–703.
4. Ohteki, T., S. Ho, H. Suzuki, T.W. Mak, and P.S. Ohashi.
1997. Role for IL-15/IL-15 receptor beta-chain in natural
killer 1.1
 
1
 
 T cell receptor-alpha beta
 
1
 
 cell development. 
 
J.
Immunol.
 
 159:5931–5935.
5. Suzuki, H., G.S. Duncan, H. Takimoto, and T.W. Mak.
1997. Abnormal development of intestinal intraepithelial
lymphocytes and peripheral natural killer cells in mice lacking
the IL-2 receptor beta chain. 
 
J. Exp. Med.
 
 185:499–505.
 
6. Zhang, X., S. Sun, I. Hwang, D.F. Tough, and J. Sprent.
1998. Potent and selective stimulation of memory-phenotype
CD8
 
1
 
 T cells in vivo by IL-15. 
 
Immunity.
 
 8:591–599.
7. Kennedy, M.K., M. Glaccum, S.N. Brown, E.A. Butz, J.L.
Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C.R.
Willis, K. Brasel, P.J. Morrissey, K. Stocking, J.C.L. Schuh,
S. Joyce, and J.J. Peschon. 2000. Reversible defects in natural
killer and memory CD8 T cell lineages in interleukin 15–defi-
cient mice. 
 
J. Exp. Med
 
. 191:771–780.
8. Lodolce, J.P., D.L. Boone, S. Chai, R.E. Swain, T. Dassop-
oulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains
lymphoid homeostasis by supporting lymphocyte homing
and proliferation. 
 
Immunity.
 
 9:669–676.
9. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller,
and I. Horak. 1993. Ulcerative colitis-like disease in mice
with a disrupted interleukin-2 gene. 
 
Cell.
 
 75:253–261.
10. Willerford, D.M., J. Chen, J.A. Ferry, L. Davidson, A. Ma,
and F.W. Alt. 1995. Interleukin-2 receptor alpha chain regu-
lates the size and content of the peripheral lymphoid com-
partment. 
 
Immunity.
 
 3:521–530.
11. Carson, W.E., J.G. Giri, M.J. Lindemann, M.L. Linett, M.
Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grab-
stein, and M.A. Caligiuri. 1994. Interleukin (IL) 15 is a novel
cytokine that activates human natural killer cells via compo-
nents of the IL-2 receptor. 
 
J. Exp. Med.
 
 180:1395–1403.
12. Mrozek, E., P. Anderson, and M.A. Caligiuri. 1996. Role of
interleukin-15 in the development of human CD56
 
1
 
 natural
killer cells from CD34
 
1
 
 hematopoietic progenitor cells.
 
Blood.
 
 87:2632–2640.
13. Leclercq, G., V. Debacker, M. de Smedt, and J. Plum. 1996.
Differential effects of interleukin-15 and interleukin-2 on
differentiation of bipotential T/natural killer progenitor cells.
 
J. Exp. Med.
 
 184:325–336.
14. Quinn, L.S., K.L. Haugk, and K.H. Grabstein. 1995. Inter-
leukin-15: a novel anabolic cytokine for skeletal muscle. 
 
En-
docrinology.
 
 136:3669–3672.
15. Reinecker, H.C., R.P. MacDermott, S. Mirau, A. Dignass,
and D.K. Podolsky. 1996. Intestinal epithelial cells both ex-
press and respond to interleukin 15. 
 
Gastroenterology.
 
 111:
1706–1713.
16. Oppenheimer-Marks, N., R.I. Brezinschek, M. Mohamadza-
deh, R. Vita, and P.E. Lipsky. 1998. Interleukin 15 is produced
by endothelial cells and increases the transendothelial migration
of T cells in vitro and in the SCID mouse–human rheumatoid
arthritis model in vivo. 
 
J. Clin. Invest.
 
 101:1261–1272.
17. Biron, C.A., K.B. Nguyen, G.C. Pien, L.P. Cousens, and
T.P. Salazar-Mather. 1999. Natural killer cells in antiviral de-
fense: function and regulation by innate cytokines. 
 
Annu.
Rev. Immunol.
 
 17:189–220.
18. Giri, J.G., S. Kumaki, M. Ahdieh, D.J. Friend, A. Loomis, K.
Shanebeck, R. DuBose, D. Cosman, L.S. Park, and D.M.
Anderson. 1995. Identification and cloning of a novel IL-15
binding protein that is structurally related to the alpha chain
of the IL-2 receptor. 
 
EMBO (Eur. Mol. Biol. Organ.) J.
 
 14:
3654–3663.
19. Van Parijs, L., Y. Refaeli, J.D. Lord, B.H. Nelson, A.K. Ab-
bas, and D. Baltimore. 1999. Uncoupling IL-2 signals that
regulate T cell proliferation, survival, and Fas-mediated acti-
vation-induced cell death. 
 
Immunity.
 
 11:281–288.